New survey reveals strong GP support for HPV self-collection but knowledge gaps remain on extended genotyping
A new nationwide survey of general practitioners (GPs) has highlighted a gap in awareness and…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Lower dose of abiraterone acetate as effective for prostate cancer treatment
Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National…
New CDK4/6 inhibitor tibremciclib shows promise in advanced breast cancer
A new targeted treatment could offer fresh hope for women with advanced hormone receptor–positive (HR+)…
Young women with breast cancer have low long-term local recurrence risk, study finds
Large multicentre cohort shows no significant differences in recurrence rates by surgery type or tumour…
A single genetic mutation may have made humans more vulnerable to cancer than chimpanzees
New research from the UC Davis Comprehensive Cancer Center, USA, has uncovered an evolutionary change…
Gut microbes key to understanding how exercise boosts cancer immunity
A new study from the University of Pittsburgh, USA, shows, for the first time, how exercise…
Children living near oil and gas wells face higher risk of rare leukaemia
Lisa McKenzie, University of Colorado Anschutz Medical Campus, and Nicole Deziel, Yale University Acute lymphocytic…
Taurine could power your energy drink – and maybe cancer cells too. Here’s what you need to know
Gulshanara (Rumy) Begum, University of Westminster Energy drinks are big business. Marketed as quick fixes…
Muscle weakness in cancer survivors may be caused by treatable weakness in blood vessels – new research
Jalees Rehman, University of Illinois Chicago Tumours can destroy the blood vessels of muscles even…
‘Fiery’ cell death during bladder cancer treatment may trigger chemotherapy resistance
Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that…